Japan Meningococcal Vaccines Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Meningococcal Vaccines market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Meningococcal Vaccines market. Detailed analysis of key players, along with key growth strategies adopted by Meningococcal Vaccines industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Sanofi

    • JN-International Medical

    • Baxter International

    • Novartis International

    • GlaxoSmithKline

    • Pfizer

    By Type:

    • Menactra

    • Menomune

    By End-User:

    • Pneumonia

    • Meningitis

    • Bacteremia

    • Others (Arthritis, Conjunctivitis, Urethritis)

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Meningococcal Vaccines Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Meningococcal Vaccines Market Size and Growth Rate of Menactra from 2014 to 2026

      • 1.3.2 Japan Meningococcal Vaccines Market Size and Growth Rate of Menomune from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Market Size and Growth Rate of Pneumonia

      • 1.4.2 Market Size and Growth Rate of Meningitis

      • 1.4.3 Market Size and Growth Rate of Bacteremia

      • 1.4.4 Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis)

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Meningococcal Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Meningococcal Vaccines by Major Types

      • 3.4.1 Japan Meningococcal Vaccines Market Size and Growth Rate of Menactra from 2014 to 2026

      • 3.4.2 Japan Meningococcal Vaccines Market Size and Growth Rate of Menomune from 2014 to 2026

    4 Segmentation of Meningococcal Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Meningococcal Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Meningococcal Vaccines in Pneumonia

      • 4.4.2 Market Size and Growth Rate of Meningococcal Vaccines in Meningitis

      • 4.4.3 Market Size and Growth Rate of Meningococcal Vaccines in Bacteremia

      • 4.4.4 Market Size and Growth Rate of Meningococcal Vaccines in Others (Arthritis, Conjunctivitis, Urethritis)

    5 Market Analysis by Regions

    • 5.1 Japan Meningococcal Vaccines Production Analysis by Regions

    • 5.2 Japan Meningococcal Vaccines Consumption Analysis by Regions

    6 Hokkaido Meningococcal Vaccines Landscape Analysis

    • 6.1 Hokkaido Meningococcal Vaccines Landscape Analysis by Major Types

    • 6.2 Hokkaido Meningococcal Vaccines Landscape Analysis by Major End-Users

    7 Tohoku Meningococcal Vaccines Landscape Analysis

    • 7.1 Tohoku Meningococcal Vaccines Landscape Analysis by Major Types

    • 7.2 Tohoku Meningococcal Vaccines Landscape Analysis by Major End-Users

    8 Kanto Meningococcal Vaccines Landscape Analysis

    • 8.1 Kanto Meningococcal Vaccines Landscape Analysis by Major Types

    • 8.2 Kanto Meningococcal Vaccines Landscape Analysis by Major End-Users

    9 Chubu Meningococcal Vaccines Landscape Analysis

    • 9.1 Chubu Meningococcal Vaccines Landscape Analysis by Major Types

    • 9.2 Chubu Meningococcal Vaccines Landscape Analysis by Major End-Users

    10 Kinki Meningococcal Vaccines Landscape Analysis

    • 10.1 Kinki Meningococcal Vaccines Landscape Analysis by Major Types

    • 10.2 Kinki Meningococcal Vaccines Landscape Analysis by Major End-Users

    11 Chugoku Meningococcal Vaccines Landscape Analysis

    • 11.1 Chugoku Meningococcal Vaccines Landscape Analysis by Major Types

    • 11.2 Chugoku Meningococcal Vaccines Landscape Analysis by Major End-Users

    12 Shikoku Meningococcal Vaccines Landscape Analysis

    • 12.1 Shikoku Meningococcal Vaccines Landscape Analysis by Major Types

    • 12.2 Shikoku Meningococcal Vaccines Landscape Analysis by Major End-Users

    13 Kyushu Meningococcal Vaccines Landscape Analysis

    • 13.1 Kyushu Meningococcal Vaccines Landscape Analysis by Major Types

    • 13.2 Kyushu Meningococcal Vaccines Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Sanofi

      • 14.1.1 Sanofi Company Profile and Recent Development

      • 14.1.2 Sanofi Market Performance

      • 14.1.3 Sanofi Product and Service Introduction

    • 14.2 JN-International Medical

      • 14.2.1 JN-International Medical Company Profile and Recent Development

      • 14.2.2 JN-International Medical Market Performance

      • 14.2.3 JN-International Medical Product and Service Introduction

    • 14.3 Baxter International

      • 14.3.1 Baxter International Company Profile and Recent Development

      • 14.3.2 Baxter International Market Performance

      • 14.3.3 Baxter International Product and Service Introduction

    • 14.4 Novartis International

      • 14.4.1 Novartis International Company Profile and Recent Development

      • 14.4.2 Novartis International Market Performance

      • 14.4.3 Novartis International Product and Service Introduction

    • 14.5 GlaxoSmithKline

      • 14.5.1 GlaxoSmithKline Company Profile and Recent Development

      • 14.5.2 GlaxoSmithKline Market Performance

      • 14.5.3 GlaxoSmithKline Product and Service Introduction

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Profile and Recent Development

      • 14.6.2 Pfizer Market Performance

      • 14.6.3 Pfizer Product and Service Introduction

     

    The List of Tables and Figures (Totals 94 Figures and 193 Tables)

    • Figure Japan Meningococcal Vaccines Market Size and Growth Rate of Menactra from 2014 to 2026

    • Figure Japan Meningococcal Vaccines Market Size and Growth Rate of Menomune from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Market Size and Growth Rate of Pneumonia

    • Figure Market Size and Growth Rate of Meningitis

    • Figure Market Size and Growth Rate of Bacteremia

    • Figure Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis)

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Meningococcal Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Meningococcal Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Meningococcal Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of Meningococcal Vaccines by Different Types from 2014 to 2026

    • Figure Japan Meningococcal Vaccines Market Size and Growth Rate of Menactra from 2014 to 2026

    • Figure Japan Meningococcal Vaccines Market Size and Growth Rate of Menomune from 2014 to 2026

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Meningococcal Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Meningococcal Vaccines by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Pneumonia

    • Figure Market Size and Growth Rate of Meningitis

    • Figure Market Size and Growth Rate of Bacteremia

    • Figure Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis)

    • Table Japan Meningococcal Vaccines Production by Regions

    • Table Japan Meningococcal Vaccines Production Share by Regions

    • Figure Japan Meningococcal Vaccines Production Share by Regions in 2014

    • Figure Japan Meningococcal Vaccines Production Share by Regions in 2018

    • Figure Japan Meningococcal Vaccines Production Share by Regions in 2026

    • Table Japan Meningococcal Vaccines Consumption by Regions

    • Table Japan Meningococcal Vaccines Consumption Share by Regions

    • Figure Japan Meningococcal Vaccines Consumption Share by Regions in 2014

    • Figure Japan Meningococcal Vaccines Consumption Share by Regions in 2018

    • Figure Japan Meningococcal Vaccines Consumption Share by Regions in 2026

    • Table Hokkaido Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Hokkaido Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Meningococcal Vaccines Consumption Share by Types in 2014

    • Figure Hokkaido Meningococcal Vaccines Consumption Share by Types in 2018

    • Figure Hokkaido Meningococcal Vaccines Consumption Share by Types in 2026

    • Table Hokkaido Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Meningococcal Vaccines Consumption Share by End-Users in 2014

    • Figure Hokkaido Meningococcal Vaccines Consumption Share by End-Users in 2018

    • Figure Hokkaido Meningococcal Vaccines Consumption Share by End-Users in 2026

    • Table Tohoku Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Tohoku Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Meningococcal Vaccines Consumption Share by Types in 2014

    • Figure Tohoku Meningococcal Vaccines Consumption Share by Types in 2018

    • Figure Tohoku Meningococcal Vaccines Consumption Share by Types in 2026

    • Table Tohoku Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Tohoku Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Meningococcal Vaccines Consumption Share by End-Users in 2014

    • Figure Tohoku Meningococcal Vaccines Consumption Share by End-Users in 2018

    • Figure Tohoku Meningococcal Vaccines Consumption Share by End-Users in 2026

    • Table Kanto Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Kanto Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Kanto Meningococcal Vaccines Consumption Share by Types in 2014

    • Figure Kanto Meningococcal Vaccines Consumption Share by Types in 2018

    • Figure Kanto Meningococcal Vaccines Consumption Share by Types in 2026

    • Table Kanto Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Kanto Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Meningococcal Vaccines Consumption Share by End-Users in 2014

    • Figure Kanto Meningococcal Vaccines Consumption Share by End-Users in 2018

    • Figure Kanto Meningococcal Vaccines Consumption Share by End-Users in 2026

    • Table Chubu Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Chubu Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Chubu Meningococcal Vaccines Consumption Share by Types in 2014

    • Figure Chubu Meningococcal Vaccines Consumption Share by Types in 2018

    • Figure Chubu Meningococcal Vaccines Consumption Share by Types in 2026

    • Table Chubu Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Chubu Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Meningococcal Vaccines Consumption Share by End-Users in 2014

    • Figure Chubu Meningococcal Vaccines Consumption Share by End-Users in 2018

    • Figure Chubu Meningococcal Vaccines Consumption Share by End-Users in 2026

    • Table Kinki Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Kinki Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Kinki Meningococcal Vaccines Consumption Share by Types in 2014

    • Figure Kinki Meningococcal Vaccines Consumption Share by Types in 2018

    • Figure Kinki Meningococcal Vaccines Consumption Share by Types in 2026

    • Table Kinki Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Kinki Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Meningococcal Vaccines Consumption Share by End-Users in 2014

    • Figure Kinki Meningococcal Vaccines Consumption Share by End-Users in 2018

    • Figure Kinki Meningococcal Vaccines Consumption Share by End-Users in 2026

    • Table Chugoku Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Chugoku Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Meningococcal Vaccines Consumption Share by Types in 2014

    • Figure Chugoku Meningococcal Vaccines Consumption Share by Types in 2018

    • Figure Chugoku Meningococcal Vaccines Consumption Share by Types in 2026

    • Table Chugoku Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Chugoku Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Meningococcal Vaccines Consumption Share by End-Users in 2014

    • Figure Chugoku Meningococcal Vaccines Consumption Share by End-Users in 2018

    • Figure Chugoku Meningococcal Vaccines Consumption Share by End-Users in 2026

    • Table Shikoku Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Shikoku Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Meningococcal Vaccines Consumption Share by Types in 2014

    • Figure Shikoku Meningococcal Vaccines Consumption Share by Types in 2018

    • Figure Shikoku Meningococcal Vaccines Consumption Share by Types in 2026

    • Table Shikoku Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Shikoku Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Meningococcal Vaccines Consumption Share by End-Users in 2014

    • Figure Shikoku Meningococcal Vaccines Consumption Share by End-Users in 2018

    • Figure Shikoku Meningococcal Vaccines Consumption Share by End-Users in 2026

    • Table Kyushu Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Kyushu Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Meningococcal Vaccines Consumption Share by Types in 2014

    • Figure Kyushu Meningococcal Vaccines Consumption Share by Types in 2018

    • Figure Kyushu Meningococcal Vaccines Consumption Share by Types in 2026

    • Table Kyushu Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Kyushu Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Meningococcal Vaccines Consumption Share by End-Users in 2014

    • Figure Kyushu Meningococcal Vaccines Consumption Share by End-Users in 2018

    • Figure Kyushu Meningococcal Vaccines Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of JN-International Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JN-International Medical

    • Figure Sales and Growth Rate Analysis of JN-International Medical

    • Figure Revenue and Market Share Analysis of JN-International Medical

    • Table Product and Service Introduction of JN-International Medical

    • Table Company Profile and Development Status of Baxter International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter International

    • Figure Sales and Growth Rate Analysis of Baxter International

    • Figure Revenue and Market Share Analysis of Baxter International

    • Table Product and Service Introduction of Baxter International

    • Table Company Profile and Development Status of Novartis International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis International

    • Figure Sales and Growth Rate Analysis of Novartis International

    • Figure Revenue and Market Share Analysis of Novartis International

    • Table Product and Service Introduction of Novartis International

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.